Composition treating for AIDS and associated conditions

Abstract

The subject invention relates to a composition for treating AIDS and related conditions. The composition comprises at least one extract of a selected plant.

We claim:  
     
         1 . An AIDS and associated conditions related to AIDS treating composition which comprises: 
 a medicament selected from an extract of at lease one of the following plant families: (1.) Apocynaceae ( Pleioscarpa Bicarpellata ); (2) Annonaceae ( Cleistopholis Patens ); (3) Dichapetalaceae ( Dichapetehan Madagasca Riense ); (4) Annoceae ( Uvaristrum Pierreanum ); (5) Cynocynaceae ( Strophantus Gratus ); (6) Asclepiadaceae ( Gongronema Latifolium ); (7) Combretaceae ( Combretum Racemosum ); (8) Apocynaceae ( Alsotonia boonei ); (9) Amaranthaceae ( Alternanthera Pungens ); (10) Aroceae ( Anchomanes Differmis ); (11) Cyperaceae ( Seleria Voivinil ); (12) Anacardiaceae ( Lannea Acida ); (13) Bignoniaceae ( Kigelia Africana ); (14) Bombacaceae ( Ceiba Pentan 6 ta ); (15) Anarcardiaceae ( Antrocaryon Micraster ); (16) Bombacaceae ( Bombax Bounopozense ); (17) Anarcardiaceae ( Spondias Mombin ); (18) Caricaceae ( Carica Papaya ); (19) a glyceryl ester of any of the foregoing extracts; (20) a saponin of any of the foregoing extracts; (21) an alkaloid of any of the foregoing extracts; (22) a protein of any of the foregoing extracts; (23) a fat of any of the foregoing extracts; (24) a sugar of any of the foregoing extracts; and (25) any mixture of any of the foregoing.    
     
     
         2 . The composition of  claim 1  where the glyceryl ester is selected from the group consisting of a fatty ester derived from stearic, oleic, lauric, palmitic, myristic, erucic acids; (b) a fatty alcohol ester derived from tridecyl stearate, cetyl palmitate, stearyl stearate, ceto stearyl stearate (c) a glyceryl ester derived from glyceryl mono laurate, glyceryl mono palmitate, derived from sorbitan mono laurate, sorbitan mono palmitate, sorbitan mono stearate, sorbitan mono oleate, sorbitan tristearate, sorbitan trioleate, sorbitan sesquioleate; (e) glycerol, (f) propylene glycol; (g) polyethylene glycol, (h) pentaerythitol, and (i) a congenser ester selected from (i) polyethylene glycol laurates/stearates/oleates (ii) polyethylene glycol mono/distearate, (iii) propylene glycol mono/distearate (iv) pentaerythritol mono/di/tetra oleate, (j) a trimethylolpropane ester selected from (i) trilaurate/triooleate; and (j) a polygycerol ester selected from stearates, oleates, and ricinoleates.  
     
     
         3 . The composition of  claim 2  where the saponins comprise a glycosidic compound comprising of a steriod (c-27) or triterpenoid (c-30) saponin nucleus with one or more carbohydrate branches.  
     
     
         4 . The composition of  claim 2  where said alkaloid is selected from a true alkaloid, a proto alkaloid, or a pseudo alkaloid with or without a heterocyclic nitrogen.  
     
     
         5 . The composition of  claim 4  where said heterocyclic nitrogen is derived from ornithine, tyrosine, tryptophane, pyrindine or lysine  
     
     
         6 . A method of treating AIDS and a condition related thereto in a patient in need thereof which comprises, treating the patient with the composition as defined in  claim 1 .  
     
     
         7 . The method as defined in  claim 6  wherein the related condition is selected from the group consisting of R/P fever, chronic diarrhea, dermatitis, generalized lymphodenpathy, cough, general pain, tuberculosis, amenorrhea and a combination of any of  
     
     
         8 . The method of  claim 6  wherein said composition is administered to the patient by an administration selected from the group consisting of orally, nasally; rectally, by injection by internal routes of administration and by a combination of the foregoing. administration.  
     
     
         9 . A method of treating a patient in need thereof to restore a compromised immune system which comprises treating the patient with the composition as defined in  claim 1.